| Primary |
| Hypercholesterolaemia |
32.6% |
| Hypertension |
19.5% |
| Hyperlipidaemia |
9.1% |
| Dyslipidaemia |
8.8% |
| Diabetes Mellitus |
5.1% |
| Cardiovascular Disorder |
2.3% |
| Gastritis |
2.3% |
| Angina Pectoris |
2.0% |
| Benign Prostatic Hyperplasia |
2.0% |
| Cerebral Infarction |
2.0% |
| Diabetes Mellitus Non-insulin-dependent |
1.7% |
| Dizziness |
1.7% |
| Insomnia |
1.7% |
| Lipids Abnormal |
1.7% |
| Nasopharyngitis |
1.7% |
| Reflux Oesophagitis |
1.4% |
| Arterial Occlusive Disease |
1.1% |
| Atrial Fibrillation |
1.1% |
| Essential Hypertension |
1.1% |
| Hyperuricaemia |
1.1% |
|
| Liver Disorder |
12.0% |
| Pyrexia |
10.8% |
| Malaise |
9.6% |
| Vomiting |
8.4% |
| Rhabdomyolysis |
6.0% |
| Thrombotic Stroke |
6.0% |
| Blood Potassium Increased |
4.8% |
| Myalgia |
4.8% |
| Headache |
3.6% |
| Nephrotic Syndrome |
3.6% |
| Pancytopenia |
3.6% |
| Tumour Excision |
3.6% |
| Urosepsis |
3.6% |
| White Blood Cell Count Decreased |
3.6% |
| White Blood Cell Count Increased |
3.6% |
| Abnormal Behaviour |
2.4% |
| Anaemia |
2.4% |
| Asthma |
2.4% |
| Blood Cholinesterase Increased |
2.4% |
| Blood Lactate Dehydrogenase Increased |
2.4% |
|
| Secondary |
| Hypertension |
22.5% |
| Hypercholesterolaemia |
13.6% |
| Renal Transplant |
12.3% |
| Hyperlipidaemia |
9.9% |
| Insomnia |
5.6% |
| Dyslipidaemia |
5.3% |
| Cerebral Infarction |
3.7% |
| Gastritis |
3.2% |
| Type 2 Diabetes Mellitus |
2.9% |
| Infection |
2.7% |
| Restless Legs Syndrome |
2.7% |
| Lipids Abnormal |
2.4% |
| Dizziness |
2.1% |
| Prophylaxis |
2.1% |
| Drug Use For Unknown Indication |
1.6% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Seasonal Allergy |
1.6% |
| Arterial Occlusive Disease |
1.3% |
| Cardiac Failure Congestive |
1.3% |
| Diabetes Mellitus |
1.3% |
|
| Thrombotic Stroke |
11.3% |
| Malaise |
10.0% |
| Tracheobronchitis |
10.0% |
| Viith Nerve Paralysis |
7.5% |
| Pyrexia |
6.3% |
| Blood Creatine Phosphokinase Increased |
5.0% |
| Hepatic Function Abnormal |
5.0% |
| Oral Surgery |
5.0% |
| Thrombocytopenia |
5.0% |
| Tumour Excision |
5.0% |
| Interstitial Lung Disease |
3.8% |
| Lip Erosion |
3.8% |
| Nephrotic Syndrome |
3.8% |
| White Blood Cell Count Decreased |
3.8% |
| Blood Potassium Increased |
2.5% |
| Haematuria |
2.5% |
| Headache |
2.5% |
| Hepatitis Acute |
2.5% |
| Lipase Increased |
2.5% |
| Liver Disorder |
2.5% |
|
| Concomitant |
| Hypertension |
25.5% |
| Pustular Psoriasis |
7.7% |
| Hyperlipidaemia |
6.2% |
| Hepatitis C |
4.7% |
| Renal Transplant |
4.6% |
| Atrial Fibrillation |
4.4% |
| Insomnia |
4.4% |
| Prophylaxis |
4.3% |
| Diabetes Mellitus |
3.9% |
| Hypercholesterolaemia |
3.9% |
| Drug Use For Unknown Indication |
3.8% |
| Parkinson's Disease |
3.6% |
| Chronic Hepatitis C |
3.4% |
| Angina Pectoris |
3.2% |
| Gastritis |
3.2% |
| Osteoporosis |
3.1% |
| Rheumatoid Arthritis |
3.0% |
| Gastric Ulcer |
2.6% |
| Type 2 Diabetes Mellitus |
2.4% |
| Depression |
2.3% |
|
| Vomiting |
8.0% |
| Idiopathic Thrombocytopenic Purpura |
7.1% |
| Insomnia |
7.1% |
| Interstitial Lung Disease |
7.1% |
| Liver Disorder |
7.1% |
| Hepatic Function Abnormal |
6.2% |
| Toxic Epidermal Necrolysis |
6.2% |
| Cerebral Infarction |
4.4% |
| Hypervigilance |
4.4% |
| Platelet Count Decreased |
4.4% |
| Pleural Effusion |
4.4% |
| Rhabdomyolysis |
4.4% |
| Staphylococcal Infection |
4.4% |
| Urticaria |
4.4% |
| Loss Of Consciousness |
3.5% |
| Proteinuria |
3.5% |
| Rash |
3.5% |
| Tracheobronchitis |
3.5% |
| Ventricular Extrasystoles |
3.5% |
| Abnormal Behaviour |
2.7% |
|
| Interacting |
| Angina Pectoris |
20.0% |
| Nausea |
20.0% |
| Diarrhoea |
10.0% |
| Enteritis Infectious |
10.0% |
| Gastritis |
10.0% |
| Hyperlipidaemia |
10.0% |
| Hypertension |
10.0% |
| Insomnia |
10.0% |
|
|
